Champions Oncology is a technology-enabled research organization that provides computational and experimental platforms to accelerate drug discovery and development in oncology. The company operates three integrated business lines: translational oncology research services (its primary revenue driver), data licensing from its proprietary patient-derived xenograft models and multi-omic dataset, and Lumin Bioinformatics, a SaaS platform combining the dataset with advanced analytics. Champions serves approximately 500 pharmaceutical and biotechnology companies globally, offering services ranging from efficacy prediction and clinical trial simulation to biomarker discovery and therapeutic resistance analysis, while also developing its own oncology therapeutics pipeline.